美國(guó)NovaBios埃博拉檢測(cè)試劑盒 埃博拉檢測(cè)試劑盒

廣州健侖生物科技有限公司

本司長(zhǎng)期供應(yīng)埃博拉病毒檢測(cè)試劑盒，其主要品牌包括美國(guó)NovaBios、廣州創(chuàng)侖等CDC使用的進(jìn)口產(chǎn)品，試劑盒的實(shí)驗(yàn)方法包括膠體金方法、ELISA方法、PCR方法等。

歡迎咨詢

歡迎咨詢2042552662

埃博拉病毒IgM、IgG、ELISA檢測(cè)試劑、埃博拉快速檢測(cè)試劑盒、

埃博拉病毒核酸檢測(cè)試劑盒（熒光探針PCR）

西非工作、旅游埃博拉檢測(cè)試劑盒

美國(guó)CDC使用的埃博拉診斷試劑——美國(guó)的NovaBios

美國(guó)NovaBios 埃博拉檢測(cè)試劑盒 埃博拉檢測(cè)試劑盒

【埃博拉簡(jiǎn)介】

埃博拉（Ebola virus）又譯作伊波拉病毒。是一種十分罕見的病毒，1976年在蘇丹南部和剛果（金）（舊稱扎伊爾）的埃博拉河地區(qū)發(fā)現(xiàn)它的存在后，引起醫(yī)學(xué)界的廣泛關(guān)注和重視，“埃博拉”由此而得名。是一個(gè)用來稱呼一群屬于纖維病毒科埃博拉病毒屬下數(shù)種病毒的通用術(shù)語。是一種能引起人類和靈長(zhǎng)類動(dòng)物產(chǎn)生埃博拉出血熱的烈性傳染病病毒，有很高的死亡率，在50%至90%之間，致死原因主要為中風(fēng)、心肌梗塞、低血容量休克或多發(fā)性器官衰竭。

埃博拉出血熱（EBHF）是由一種絲狀病毒感染導(dǎo)致的急性出血性、動(dòng)物源性傳染病。1976年，埃博拉出血熱在非洲的蘇丹和扎伊爾暴發(fā)，病死率高達(dá)50% ～ 90% 。因該病始發(fā)于扎伊爾北部的埃博拉河流，并在該區(qū)域嚴(yán)重流行，故命名為埃博拉病毒，其形態(tài)學(xué)、致病性等與馬爾堡病毒相似，但免疫原性有所區(qū)別。

【產(chǎn)品介紹】

該產(chǎn)品是世界衛(wèi)生組織（WHO）*個(gè)批準(zhǔn)用于埃博拉病毒檢測(cè)的診斷試劑卡。不需要借助其他實(shí)驗(yàn)儀器設(shè)備，只需要采取幾滴血清、血漿、血液樣品，既可以檢測(cè)，并在15分鐘內(nèi)就可以得知結(jié)果是否感染埃博拉病毒。該產(chǎn)品具有靈敏度高、操作方便、實(shí)驗(yàn)時(shí)間短等特點(diǎn)。

美國(guó)NovaBios

這當(dāng)然是9月份當(dāng)時(shí)的估計(jì)，現(xiàn)在看來會(huì)不一定準(zhǔn)確，但zui少可以大家看清楚大概那些地方zui需要花錢，大概要多少。同時(shí)也可以給有捐款的國(guó)家和個(gè)人一些需求的信息。
　　第二個(gè)數(shù)據(jù)是關(guān)于治療患者的費(fèi)用的。美國(guó)商業(yè)媒體Bloomberg發(fā)布了一篇文章，標(biāo)題是： Bill for Ebola Adds Up as Care Costs $1,000 an Hour(治療埃博拉的費(fèi)用加起來有每小時(shí)一千美元)。 這個(gè)聽起來有點(diǎn)聳人聽聞。仔細(xì)一讀文章，原來講的是醫(yī)院在治療在美國(guó)德州埃博拉病毒的埃博拉病人Thomas Eric Duncan 時(shí)的花費(fèi)情況。在對(duì)這位病人的醫(yī)治過程中，每天的花費(fèi)大概在18,000到24,000之間，報(bào)道時(shí)去上限，得到每小時(shí)一千美元的估計(jì)。我想花在給非洲的病人治病的花費(fèi)肯定比這個(gè)數(shù)字要小太多。
　　第三個(gè)數(shù)據(jù)是關(guān)于誰出錢的問題的。這里有個(gè)表，是對(duì)應(yīng)當(dāng)時(shí)下六個(gè)月所需的987.8M美元的來源的。在當(dāng)時(shí)的這些捐款中，世界銀行，美國(guó)，非洲發(fā)展銀行占了大頭。世界上大多數(shù)國(guó)家都多多少少有貢獻(xiàn)。資金來源和用途的透明公布有助于讓出力的國(guó)家，組織和個(gè)人對(duì)資金的合理運(yùn)用有及時(shí)了解，這樣也可以促進(jìn)更多的力量來加入抗擊疾病的*中。
埃博拉病毒主要是通過病人的血液、唾液、汗水和分泌物等途徑傳播。實(shí)驗(yàn)室檢查常見淋巴細(xì)胞減少，血小板嚴(yán)重減少和轉(zhuǎn)氨酶升高（AST>ALT），有時(shí)血淀粉酶也增高。診斷可用ELISA檢測(cè)特異性IgG抗體（出現(xiàn)IgM抗體提示近期感染）；用ELISA檢測(cè)血液、血清或組織勻漿中的抗原；用IFA通過單克隆抗體檢測(cè)肝細(xì)胞中的病毒抗原；或者通過細(xì)胞培養(yǎng)或豚鼠接種分離病毒。用電子顯微鏡有時(shí)可在肝切片中觀察到病毒。用IFA檢測(cè)抗體常導(dǎo)致誤判，特別是在進(jìn)行既往感染的血清學(xué)調(diào)查時(shí)。實(shí)驗(yàn)室研究有很大的危險(xiǎn)性，應(yīng)該只在有防護(hù)措施防止工作人員和社區(qū)感染的地方開展（4級(jí)生物安全實(shí)驗(yàn)室）。
感染潛伏期為2天左右。感染者均是突然出現(xiàn)高燒、頭痛、咽喉疼、虛弱和肌肉疼痛。然后是嘔吐、腹痛、腹瀉。發(fā)病后的兩星期內(nèi)，病毒外溢，導(dǎo)致人體內(nèi)外出血、血液凝固、壞死的血液很快傳及全身的各個(gè)器官，病人zui終出現(xiàn)口腔、鼻腔和埃博拉出血等癥狀，患者可在24小時(shí)內(nèi)死亡。
在大約1500例確診的埃博拉案例中，死亡率高達(dá)88%。

美國(guó)NovaBios

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

想了解更多的NovaBios產(chǎn)品及服務(wù)請(qǐng)掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場(chǎng)部】    楊永漢

【】 
【騰訊  】 2042552662
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-103室

This is of course the estimate of September, and now it seems not necessarily accurate, but at least you can see where the most need to spend money, probably how much. At the same time can also give some information on the needs of countries and individuals with donations.
The second data is about the cost of treating the patient. American business media Bloomberg has published an article titled: Bill for Ebola Adds Up as Care Costs $ 1,000 an Hour (the cost of treating Ebola is $ 1,000 per hour). This sounds a bit sensational. Carefully read the article, the original is about the hospital in the treatment of the United States in Germany Ebola virus Ebola patients Thomas Eric Duncan when the cost of the situation. In the treatment of the patient, the daily cost of about 18,000 to 24,000, reported to the upper limit, get an estimated one thousand dollars per hour. I would like to spend too much on the cost of treating a patient in Africa.
The third data is about who is paying the question. There is a table that is the source of the $ 987.8M required for the next six months. At the time of the donations, the World Bank, the United States, the African Development Bank accounted for the bulk. Most countries in the world have contributed more or less. Transparent disclosure of sources and uses of funds helps countries, organizations and individuals to make informed use of the rational use of funds, which can also promote more power to join the fight against disease.
Ebola virus is mainly through the patient's blood, saliva, sweat and secretions and other means of transmission. Laboratory examination of common lymphopenia, severe reduction of plaets and elevated transaminase (AST> ALT), and sometimes increased serum amylase. Diagnostic ELISA can be used to detect specific IgG antibodies (IgM antibodies suggest recent infection); ELISA to detect blood, serum or tissue homogenate antigen; with IFA by monoclonal antibody detection of liver cells in the virus antigen; or by cell culture or Guinea pigs were inoculated to isolate the virus. Electron microscopy can sometimes be observed in the liver slices of the virus. Detection of antibodies with IFA often leads to miscarriage of justice, especially when conducting serological investigations of previous infections. Laboratory studies are highly risky and should be carried out only in areas where protective measures prevent workers and communities from infecting (Level 4 Biosafety Laboratories).
Infection latency is about 2 days. Infected people are suddenly high fever, headache, sore throat, weakness and muscle pain. Then vomiting, abdominal pain, diarrhea. Within two weeks after the onset of the virus spill, leading to internal and external bleeding, blood coagulation, necrotic blood quickly pass and the body of the various organs, the patient eventually appear oral, nasal and Ebola bleeding symptoms, the patient can be within 24 hours death.
In about 1500 confirmed Ebola cases, the mortality rate was as high as 88%.